The tuberous sclerosis genes and regulation of the cyclin-dependent kinase inhibitor p27 [An article from: Mutation Research-Reviews in Mutation Research] | ![The tuberous sclerosis genes and regulation of the cyclin-dependent kinase inhibitor p27 [An article from: Mutation Research-Reviews in Mutation Research]](http://ecx.images-amazon.com/images/I/51D5XTYSJSL._SL160_.jpg) | Authors: M. Rosner, A. Freilinger, M. Hengstschlager
Publisher: Elsevier
Category: Book
Buy New: $14.95
as of 2/12/2012 18:52 PST details
In Stock
Seller: Amazon.com
Format: HTML
Language: English (Published)
Media: Digital
Pages: 6
Availability: Available for download now
| | |
| Editorial Reviews:
Product Description
This digital document is a journal article from Mutation Research-Reviews in Mutation Research, published by Elsevier in 2006. The article is delivered in HTML format and is available in your Amazon.com Media Library immediately after purchase. You can view it with any web browser.
Description:
Tuberous sclerosis complex (TSC) is an autosomal dominant tumor syndrome that affects ~1 in 6000 individuals. It is characterized by the development of tumors, named hamartomas, in the kidneys, heart, skin and brain. The latter often cause seizures, mental retardation, and a variety of developmental disorders, including autism. This disease is caused by mutations within the tumor suppressor gene TSC1 on chromosome 9q34 encoding hamartin or within TSC2 on chromosome 16p13.3 encoding tuberin. TSC patients carry a mutant TSC1 or TSC2 gene in each of their somatic cells, and loss of heterozygosity has been documented in a wide variety of TSC tumors. Recent data suggest that functional inactivation of TSC proteins might also be involved in the development of other diseases not associated with TSC, such as sporadic bladder cancer, breast cancer, ovarian carcinoma, gall bladder carcinoma, non-small-cell carcinoma of the lung, and Alzheimer's disease. Tuberin and hamartin form a heterodimer, suggesting they might affect the same processes. Tuberin is assumed to be the functional component of the complex and has been implicated in the regulation of different cellular functions. The TSC proteins regulate cell size control due to their involvement in the insulin signalling pathway. Furthermore, they are potent positive regulators of the cyclin-dependent kinase inhibitor p27, a major regulator of the mammalian cell cycle. Here we review the current knowledge on how mutations within the TSC genes could trigger deregulation of stability and localization of the tumor suppressor p27.
|
| |
| In Stock
|
|
|
